⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SRPT News
Sarepta Therapeutics,, Inc. Common Stock
Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results
businesswire.com
SRPT
Kuehn Law Encourages Investors of Sarepta Therapeutics, Inc. to Contact Law Firm
prnewswire.com
SRPT
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
prnewswire.com
IOBT
SRPT
AUTL
ARCT
IOBT
SRPT
AUTL
ARCT
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2025-2026 Academic Year
businesswire.com
SRPT
Class Action Filed Against Sarepta Therapeutics, Inc. (SRPT) Seeking Recovery for Investors - Contact The Gross Law Firm
prnewswire.com
SRPT
SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT
prnewswire.com
SRPT
SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
SRPT
SRPT Deadline: SRPT Investors with Losses in Excess of $100K Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
SRPT
INVESTOR DEADLINE MONDAY: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - SRPT
prnewswire.com
SRPT
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT
prnewswire.com
SRPT